Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease

• Main Authors: Rajmohan Dharmaraj (Author), Tess Pei Lemon (Author), Rasha Elmaoued (Author), Ricardo Orlando Castillo (Author), Razan Alkhouri (Author)
• Format: Book
• Published: MDPI AG, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Infliximab (IFX) is a recombinant DNA-derived chimeric IgG monoclonal antibody protein that inhibits tumor necrosis factor alpha (TNF-α). IFX, like other agents derived from foreign proteins, can cause infusion reactions both during and after the infusion. The incidence of infusion reactions ranges...